TI - Pazopanib or Sunitinib as First-Line Treatment in metastatic Renal Cell Cancers: A Retrospective Comparative Analysis of Survival and Toxicity Outcomes
PT - Journal Article
DP - 2025
TA - EJMI
PG - 97-104
VI - 9
IP - 2
AID - 2025.81571 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2025.81571
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2025 9(2): 97